Ron Bentsur - SEC Form 4 Insider Trading Activity
Summary
Updated Aug 4, 2026
Ron Bentsur has filed 1 SEC Form 4 filing across 1 company in the last 90 days - buying. Lifetime open-market purchases: $398K.
Profile
Ron Bentsur holds the role of Chairman & CEO at Nuvectis Pharma, Inc. (NVCT). Bentsur's filing history also covers Beyond Air, Inc. (XAIR). Bentsur has reported 5 insider filings with the SEC since 2024. The most recent filing was in July 2026.
| Role | Chairman & CEO, Director, 10% Owner |
|---|---|
| Notability | 50/100 |
Board memberships
- Nuvectis Pharma, Inc.
- Beyond Air, Inc.
Reported roles
- Chairman & CEO
- Director
Track Record
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realised performance after each tracked open-market purchase.
| Total purchases tracked | 3 |
|---|
Trading Pattern
InsiderAlpha's records for Ron Bentsur go back to 2024: 5 primary Form 4 filings, an average of 1.7 per year. The typical open-market purchase is $99K (4 buys totaling $398K). The largest single buy on record is $250K of NVCT in 2026. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Career & Filing History
Every role Ron Bentsur has reported on a Form 4, reconstructed from the filings themselves - reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
- Chairman & CEO, Director, 10% Owner at Nuvectis Pharma, Inc. (NVCT) - 4 filings, 2024 to 2026
- Director at Beyond Air, Inc. (XAIR) - 1 filing, 2024
Recent Transactions
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-01 | NVCT | Nuvectis Pharma, Inc. | P - Open-market purchase | 12.5K | $20.00 | $250K |
| 2025-11-06 | NVCT | Nuvectis Pharma, Inc. | P - Open-market purchase | 5.0K | $5.72 | $29K |
| 2024-12-26 | NVCT | Nuvectis Pharma, Inc. | P - Open-market purchase | 4.5K | $4.65 | $21K |
| 2024-11-18 | NVCT | Nuvectis Pharma, Inc. | P - Open-market purchase | 20.0K | $4.92 | $98K |
Companies - Last 90 Days
- Nuvectis Pharma, Inc. (NVCT) - 1 filing, last 2026-07-01
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades at the companies Ron Bentsur has recently filed at. Multiple unrelated insiders buying the same stock within a short window - cluster buying - has historically been one of the strongest Form 4 signals.
- Marlio Charles Mosseri - $1.87M of NVCT open-market activity in the last 12 months
- Juan Sanchez - $75K of NVCT open-market activity in the last 12 months
- Matthew L. Kaplan - $64K of NVCT open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
- Saul B. Rosenthal
- Jack Ross
- Martine A. Rothblatt
- Saba Capital Management, L.P.
- Nicholas S. Schorsch
- Trygve Seglem
- Lawrence B. Seidman
- Thomas J. Shaw
Frequently Asked Questions
Who is Ron Bentsur?
Ron Bentsur holds the role of Chairman & CEO at Nuvectis Pharma, Inc. (NVCT). Bentsur's filing history also covers Beyond Air, Inc. (XAIR). Bentsur has reported 5 insider filings with the SEC since 2024. The most recent filing was in July 2026.…
How many SEC Form 4 filings has Ron Bentsur submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Ron Bentsur been buying or selling stock?
Recorded transactions: 4 open-market purchases ($398K) and 0 open-market sales across all tracked filings.
How accurate is Ron Bentsur's historical track record?
Across 3 tracked purchases, Ron Bentsur averaged no 30-day data yet with a win rate pending. InsiderAlpha rates the track record at –/5 stars.
Where can I see all of Ron Bentsur's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Open the live Ron Bentsur profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.